Podcast

Thomas Seck, MD, on the EMPA-REG OUTCOME Trial: Empagliflozin Reduces CV Risk by 38%

10/09/2017

 

Thomas Seck, MD, vice president of Clinical Development and Medical Affairs – Primary Care at Boehringer Ingelheim Pharmaceuticals, Inc., spoke with us about the results of the landmark EMPA-REG OUTCOME Trial and what they mean for the treatment of diabetes and cardiovascular disease.

To read more about the EMPA-REG OUTCOME Trial, read our news brief here.

For more cardiology or diabetes content, visit our Medical Resource Centers.

Related Content

Diabetes
Diabetes
Laura Hollar, MD, on Diabetes and Vitamin D Deficiency
06/14/2018
In this podcast, Dr Laura Hollar from Washington University School of Medicine discusses her latest Diabetes Q&A column about the interaction between diabetes and vitamin D deficiency.
06/14/2018
Infectious Diseases
Infectious Diseases
Valerie Delpech, MBBS, MPH, on the Trends of HIV Infection in the United Kingdom
06/05/2020
She speaks about the UK HIV epidemic and the programs that were implemented that helped reduce the number of HIV infections in the region.
06/05/2020
Surgery
Surgery
Nicole Basa, MD, on Whether Bariatric Surgery Is Right for Your Patient
11/29/2018
Dr Nicole Basa of Cedar Park Surgeons discusses the most commonly performed bariatric procedures, ideal candidates, and how clinicians can support their patients pre- and post-surgery.
11/29/2018
Podcasts
Podcasts
Karen Edison, MD, on Dermatology for Primary Care: An Overview of the ECHO Program
08/03/2017
<p>Dr. Karen Edison, from the University of Missouri and the dermatology ECHO Program, discusses the ECHO program and how primary care providers can participate.</p>
08/03/2017
Stress and Burnout
Stress and Burnout
Jean Liew, MD, on Disease Activity in Axial Spondyloarthritis During the Pandemic
10/27/2020
In this podcast, Jean Liew, MD, discusses the association between stress, anxiety, and axSpA during the pandemic and what it suggests about the importance of stress/anxiety management among patients with...
10/27/2020